Results 291 to 300 of about 292,424 (340)

Metformin‐Based Covalent Organic Frameworks With Excellent Biosafety and High Efficiency against Pathogenic Microorganisms

Advanced Science, EarlyView.
This work presents the first metformin‐based COFs featuring built‐in biosafety and a unique triple‐synergy mechanism. This scalable platform achieves broad‐spectrum eradication of bacteria and viruses, enabling reusable protective membranes with exceptional biocompatibility for advanced biomedical applications and personal protection.
Jia‐Yi Liu, Hong Jiang, Lei Ma, Jin‐Yi Yu, Ming‐Yi Yang, Hao‐Ru Wang, Jun‐Yuang Tang, Shengfeng Huang, Wei Yi, Meng Lu, Ya‐Qian Lan, Xu‐Jia Hong   +11 more
wiley   +1 more source

Real-life use of isavuconazole in Spanish children and adolescents. [PDF]

J Antimicrob Chemother
Mendoza-Palomar N, Simó Nebot S, Roig-Soria L, Alonso García L, Izquierdo Anto C, García Ascaso MT, Díaz Pérez D, Grasa Lozano C, Jiménez Núñez C, Rincón López EM, Navarro Gómez ML, Carazo Gallego B, Álvarez Vallejo B, Ramos Amador JT, Manzanares Á, Jiménez Montero B, Noguera Julian A, Soler-Palacin P.   +17 more
europepmc   +1 more source

The impact of pathological fluctuations versus biological variation on the interpretation of laboratory values. [PDF]

Pract Lab Med
Ortiz AM, Emond JP, Cheung VW, Saeed S, Desmarais P, Larivière F, Hétu PO, Goulden R, Nguyen QD.   +8 more
europepmc   +1 more source

Exploration of Multiple Non-Invasive Tests for Assessing Response to Treatment in a Semaglutide Phase 2b Trial in Patients with MASH. [PDF]

Aliment Pharmacol Ther
Nitze LM, Ratziu V, Sanyal AJ, Wong VW, Balendran C, Fleckner J, Skalshøi Kjær M, Krarup N, Anstee QM.   +8 more
europepmc   +1 more source

Fontan-Associated Liver Disease: Trends Over Time and Relationship With Outcomes. [PDF]

J Am Heart Assoc
Janzen M, Khakh P, Peng D, Sathananthan G, Kiess M, Chakrabarti S, Grewal J.   +6 more
europepmc   +1 more source

Reply to the comment on “High-normal and abnormal alanine transaminase levels linked to increased risk of hepatoma following treatment for chronic hepatitis C”

Yen‐Chun Chen, Ming‐Lung Yu
openalex   +1 more source

Impact of statins on liver transaminases in patients with metabolic dysfunction-associated steatotic liver disease: A 12-month retrospective review. [PDF]

Hepatol Forum
Wong PJW, Ng SC, George S, Rasdi RB.
europepmc   +1 more source